Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Noevir Holdings CoTSE:4928 -0.43%79 ROE % is 10.44% as of Dec. 2025, which is 25% below its 10-year median of 13.98. GuruFocus rates TSE:4928 with a GF Score™ of 79/100 and a GF Value™ of 円5,265.32 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,924 Consumer Packaged Goods companies, Noevir Holdings Co ranks better than 79.26% on this metric.
The historical rank and industry rank for Noevir Holdings Co's ROE % or its related term are showing as below:
TSE:4928'
s ROE % Range Over the Past 10 Years
Min: 9.16 Med: 13.98 Max: 16.33
Current: 16.33
During the past 13 years, Noevir Holdings Co's highest ROE % was 16.33%. The lowest was 9.16%. And the median was 13.98%.
TSE:4928's ROE % is ranked better than 79.26% of 1924
companies
in the Consumer Packaged Goods industry
Industry Median: 6.785
vs TSE:4928: 16.33
Noevir Holdings Co (TSE:4928) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Noevir Holdings Co ROE % Related Terms
Noevir Holdings Co ROE % Historical Data
* Premium members only.
The historical data trend for Noevir Holdings Co's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Noevir Holdings Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noevir Holdings Co ROE % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's ROE % distribution charts can be found below:
* The bar in red indicates where Noevir Holdings Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Noevir Holdings Co (TSE:4928) has a ROE % of 10.44% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Noevir Holdings Co and its competitors. This is 25% below median its historical median of 13.98. Over the past decade, Noevir Holdings Co's ROE % has ranged from 9.16 to 16.33. According to the industry distribution chart, Noevir Holdings Co ranks #399 out of 1924 companies in the Consumer Packaged Goods industry, placing it in the top 20.7%.
Is Noevir Holdings Co's ROE % too high?
Noevir Holdings Co's current ROE % of 10.44% is 25% below median its 10-year median of 13.98. Over the past 10 years, this metric has ranged from a low of 9.16 to a high of 16.33. The Consumer Packaged Goods industry median ROE % is 6.79. Noevir Holdings Co's value of 10.44% is 53.9% above this industry median. Based on the distribution chart, Noevir Holdings Co ranks #399 out of 1924 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Noevir Holdings Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's ROE % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Noevir Holdings Co ranks #399 out of 1924 companies for ROE %. This places Noevir Holdings Co in the top 21% of its industry — outperforming the majority of peers. The industry median ROE % is 6.79. Noevir Holdings Co's value of 10.44% is 53.9% above this benchmark. Historically, Noevir Holdings Co's own ROE % has ranged from 9.16 to 16.33 over the past decade. While the company's 10-year median is 13.98 vs. the industry median of 6.79, Noevir Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Consumer Packaged Goods company?
The median ROE % among Consumer Packaged Goods companies is 6.79, based on 1,924 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Noevir Holdings Co's current ROE % of 10.44% is 53.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Noevir Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median ROE % is 6.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Noevir Holdings Co's current ROE % is 10.44%, which is 25% below median its own 10-year median of 13.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Modestly Undervalued. The stock's GF Value™ is 円5,265.32, compared to a current price of 円4,585.00 — trading 12.9% below its estimated fair value. The current ROE % is 10.44%, which is 25% below median its 10-year median of 13.98 and 53.9% above the Consumer Packaged Goods industry median of 6.79. Noevir Holdings Co's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current ROE % is 10.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?
Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued.
The current stock price of 円4,585.00 is trading 12.9% below its estimated GF Value™ of 円5,265.32.
GuruFocus considers Noevir Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:4928:
ROE %: 10.44% (25% below median its 10-year median of 13.98)
GF Value™: 円5,265.32 vs. price of 円4,585.00 (12.9% below fair value)
Industry Position: 53.9% above the Consumer Packaged Goods median (#399 of 1924)
No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
79GF Score
Get the complete analysis for TSE:4928
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4928 has been successfully added to your 
